Hypertension Trial, Recruiting NCT07116096 Sponsor: Shanxi Provincial People's Hospital Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07116096
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been clinically diagnosed with liver cirrhosis (scarring of the liver)
  • People whose endoscopy (a camera procedure to look inside the digestive tract) has confirmed the presence of enlarged veins (varices) in the esophagus or stomach
  • For the portal vein pressure measurement part of the trial only: people who have had no signs of bleeding from these enlarged veins for at least 14 days
  • People (or their legal guardian) who are able to understand the study, are willing to take part, and can sign a written consent form

Who may not be able to join:

  • People with severe heart failure, or severe untreated heart valve disease
  • People with moderate to severe high blood pressure in the lungs (pulmonary hypertension)
  • People with an active, uncontrolled infection anywhere in the body
  • People who have cysts, tumours, or other growths in the liver tissue that would prevent a specific procedure called TIPS (a procedure to reduce pressure in liver blood vessels) from being performed
  • People experiencing obvious symptoms of hepatic encephalopathy (confusion or mental changes caused by the liver not filtering toxins properly)
  • People with a blockage in the bile ducts that has not been treated or relieved
  • People with a Child-Pugh score above 13 (a measure of liver disease severity — confirm with trial site)
  • People with a MELD score above 18 (another measure of liver disease severity — confirm with trial site)
  • People with an INR above 5 (a blood test result measuring how well blood clots)
  • People with a platelet count below 20 ×10⁹/mm³ (platelets are blood cells that help with clotting; this indicates a very low level)
  • People who have no gastrointestinal bleeding may be excluded from certain parts of the trial (specifically the ultrasound and endoscopic ultrasound groups — confirm with trial site which group applies)
  • People who have had surgery on their hand or wrist in the past 3 months, or who are unable to grip a handheld strength-measuring device with their testing hand

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 134 8537 1098

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanxi Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
17 August 2025
Est. completion
15 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

portal pressure; left gastric vein pressure; portal flow velocity; Portal vein blood flow direction; Blood flow velocity in esophageal varices; Blood flow direction of esophageal varices; Diameter of esophageal varices; Heart rate; blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov